Pattern

CJC-1295 (with DAC)

Retail$700.00$560.0010-vial kit

Overview

Research-use GHRH analogue with DAC modification supplied for studies of sustained somatotropic-axis signaling models.

Concentration
5 mg
Stock
In stock

Material profile

CJC-1295 with DAC is a modified GHRH analogue used in research models of sustained somatotropic-axis signaling. Pattern lists this material for controlled laboratory research.

Research Targets
GHRH receptor signaling, albumin-binding pharmacokinetic models, pituitary somatotroph pathways.
Key Feature
DAC modification designed for extended experimental exposure windows.
Research Focus Areas
Somatotroph stimulation, GH/IGF-1 pathway signaling, endocrine feedback modeling, pharmacokinetic study designs.
Common Models
Pituitary cell assays, rodent endocrine models, receptor-signaling experiments.
Mechanistic Interests
GHRH receptor activation, cAMP/PKA signaling, albumin-binding kinetics, downstream IGF-1 pathway markers.
Use Boundary
Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.

Product documentation

Certificate of Analysis

CJC-1295 with DAC

Review the public certificate available for this product before creating an account or checking out.

Open COAView COA library
CJC-1295 with DAC 5 mg

One kit adds 10 vials to checkout.